Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model

15 May 2019

Abstract excerpt

Hypercholesterolemia is a main risk factor of cardiovascular disease. Probiotics are a safe approach to reduce elevated cholesterol without any deleterious effect to human health.Saccharomyces boulardiiCNCM I-745 probiotic properties are well documented in a context of intestinal dysbiosis. Recentin vitroand preclinical studies have suggested its potential effects on dyslipidemia. This is the first controlled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol and Lipid Metabolism
Share to Lipoproteins and Cardiovascular Health
Share to Pharmacological Effects of Natural Compounds

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31090460
DOI: 10.3920/bm2018.0134

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic modelPMID 31090460Read ↗

Alterations of ileal mucosa-associated microbiota in hypercholesterolemia patientsSemantic proximity Read ↗

The Role of Gut Microbiota on Cholesterol Metabolism in AtherosclerosisSemantic proximity Read ↗

Molecular characterization of gut microbiota in high‑lipid diet‑induced hyperlipidemic rats treated with simvastatinSemantic proximity Read ↗

Correction of hypertriglyceridemia by intestinal microbiota remodeling alleviates NASH and atherosclerosis in severe combined hyperlipidemia diseaseSemantic proximity Read ↗

The intestinal microbiota regulates host cholesterol homeostasisSemantic proximity Read ↗

Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE−/− miceSemantic proximity Read ↗

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis &ndash; a reviewSemantic proximity Read ↗

Study on intestinal survival and cholesterol metabolism of probioticsSemantic proximity Read ↗

Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and IgnoreSemantic proximity Read ↗

Comprehensive genomic analysis of hypocholesterolemic probiotic Enterococcus faecium LR13 reveals unique proteins involved in cholesterol-assimilationSemantic proximity Read ↗

Distinct microbial taxa are associated with LDL-cholesterol reduction after 12 weeks of Lactobacillus plantarum intake in mild hypercholesterolemiaSemantic proximity Read ↗

Cardiovascular and intestinal protection of cereal pastes fermented with lactic acid bacteria in hyperlipidemic hamstersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.